TNFSF13B and atherosclerosis: Our results suggest that patients who undergo B cell depletion therapy would be protected from atherosclerosis and the B cells that regenerate in the presence of high BAFF and AngII (patients with atherosclerosis have high ACE activity) will enhance the protective effects due to their improved regulatory functions.